ADHD Treatment Denied by Insurance: How to Appeal a Claim Denial

Attention deficit hyperactivity disorder (ADHD) affects roughly 10% of children and 4–5% of adults in the United States, yet insurance coverage for its diagnosis and treatment is frequently denied or made unnecessarily difficult. Whether your insurer refused Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization for a stimulant medication, denied neuropsychological testing, or challenged an adult ADHD diagnosis, this guide explains your options.

Common ADHD Claim Denial Scenarios

Stimulant Medication Prior Authorization: FDA-approved medications for ADHD — including amphetamine salts (Adderall, Vyvanse), methylphenidate formulations (Ritalin, Concerta, Jornay PM), and newer agents like Qelbree (viloxazine) — almost universally require prior authorization. Denials commonly arise when:

• The prescriber is a primary care physician rather than a psychiatrist (some plans require specialist prescribing)
• The requested formulation is brand-name when a generic is available, even when the patient has documented differences in response or tolerability
• Step therapy requires failure of a generic methylphenidate before approving amphetamine salts, regardless of the prescriber's clinical rationale
• Quantity limits are applied that do not match the prescribed dosing regimen

Neuropsychological Testing: Comprehensive neuropsychological evaluation is often necessary to confirm ADHD diagnosis, rule out comorbidities (learning disabilities, autism spectrum disorder, anxiety), and guide treatment planning — particularly in adults. Insurers frequently deny these evaluations as "not medically necessary" or as an "educational" rather than medical service. This distinction is clinically unfounded; neuropsychological testing is a medical service with direct treatment implications.

Adult ADHD Challenges: Insurance plans sometimes apply more scrutiny to adult ADHD diagnoses, effectively treating them as less legitimate than childhood diagnoses. Denials may cite lack of childhood documentation, question diagnostic validity, or require additional evaluations not required for other psychiatric diagnoses. These practices may implicate age discrimination and Mental Health Parity Act (MHPAEA) Explained" class="auto-link">MHPAEA parity concerns.

Non-Stimulant Medication Denials: Strattera (atomoxetine), Intuniv (guanfacine ER), and Kapvay (clonidine ER) are also FDA-approved for ADHD and are often needed when stimulants are contraindicated. Insurers may require prior failure of stimulant medications before approving non-stimulants, even when the prescriber has documented clinical reasons for avoiding stimulants.

Why These Denials Are Often Legally Vulnerable

MHPAEA and ADHD: ADHD is a DSM-5 neurodevelopmental disorder covered by the Mental Health Parity and Addiction Equity Act. Prior authorization requirements for ADHD medications must be comparable to those applied to medications for similar chronic medical conditions. If your plan covers other chronic disease medications (e.g., for hypertension, diabetes, or asthma) without comparable step-therapy requirements, applying strict step therapy only to ADHD medications may constitute a parity violation.

Arbitrary step therapy: Several states have enacted step therapy override laws that require insurers to grant step therapy exceptions when a clinician documents that (1) the required first-line drug was previously tried and failed, (2) the required drug is contraindicated, (3) the required drug is likely to cause adverse reactions, or (4) the requested drug is clinically superior for the patient. If your state has a step therapy override law, your prescriber can file an exception request.

Neuropsychological testing coverage: Testing ordered by a physician to diagnose and treat a medical condition is a covered medical benefit under most plans. Denials that classify it as "educational" can often be overturned by having the ordering physician document the treatment implications — how test results will directly inform medication selection and dosing decisions.

How to Appeal ADHD Medication Denials

Step 1: Obtain the prior authorization denial with the specific clinical criteria cited.

Step 2: Have your prescribing clinician document the medical necessity rationale directly addressing the denial criteria. For brand-name versus generic disputes, document specific clinical reasons — differences in extended-release pharmacokinetics, tolerability history, or documented response differences.

Step 3: If step therapy is the barrier, request a step therapy exception. Your clinician should document: the clinical reason the preferred medication was not used, any prior trials and outcomes, and contraindications or clinical concerns with the required first-step medication.

Step 4: File an internal appeal within your plan's deadline. Include medical records, the clinician letter, and any relevant clinical guidelines (AACAP Practice Parameters, AAP Clinical Practice Guidelines for ADHD).

Step 5: If denied, request an independent External Independent Review: Complete Guide" class="auto-link">external review. External reviewers overturn ADHD medication denials at meaningful rates, particularly when step therapy exceptions are clinically documented.

For Neuropsychological Testing Denials

Have the ordering physician write a letter specifying:

• The clinical questions to be answered by testing
• How test results will directly change the treatment plan
• Why less intensive diagnostic evaluation is insufficient given the clinical complexity

Distinguish the medical purpose of testing from any educational assessment purpose — insurers cannot deny a service simply because it may also have educational benefits if it has legitimate medical indications.

Fight Back With ClaimBack

ADHD is a recognized medical condition with effective treatments. If your insurer is putting up barriers, ClaimBack helps you dismantle them with the right language, evidence, and legal framework.

Start your ADHD insurance appeal at ClaimBack

Related Reading

• How to Write an Insurance Appeal Letter That Gets Results
• What Is Medical Necessity — and How to Prove It to Your Insurer
• Common Reasons Insurance Claims Are Denied